TGFβ loss activates ADAMTS-1-mediated EGF-dependent invasion in a model of esophageal cell invasion

Experimental Cell Research

Volumn 330, Issue 1, 2015, Pages 29-42

  Le Bras, Grégoire F ^a   Taylor, Chase ^a   Koumangoye, Rainelli B ^a   Revetta, Frank ^a   Loomans, Holli A ^b   Andl, Claudia D ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

ADAMTS 1; Cell matrix interaction; ESCC; Invasion; MMP14

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ADAMTS1 PROTEIN; COLLAGEN TYPE 1; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; INTEGRIN; INTERLEUKIN 1; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; ADAM PROTEIN; ADAMTS1 PROTEIN, HUMAN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN RECEPTOR; NERVE PROTEIN; ROUNDABOUT RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM; EPITHELIUM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR INVASION; ANTAGONISTS AND INHIBITORS; CELL MOTION; ESOPHAGUS TUMOR; GENETICS; METABOLISM; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADAM PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FIBROBLASTS; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HUMANS; INTERLEUKIN-1; KERATINOCYTES; NERVE TISSUE PROTEINS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

EID: 84917737797     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.07.021     Document Type: Article

References (75)

1. Speight P.M. Update on oral epithelial dysplasia and progression to cancer. Head Neck Pathol. 2007, 1:61-66. 10.1007/s12105-007-0014-5.
2. Gannot G., Gannot I., Vered H., Buchner A., Keisari Y. Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma. Br. J. Cancer. 2002, 86:1444-1448. 10.1038/sj.bjc.6600282.
3. Gabbert H.E., Shimoda T., Hainaut P., Nakamura Y., Field J.K., Inoue H. Squamous cell carcinoma of the oesophagus. Pathology and Genetics of Tumours of the Digestive System, World Health Organization Classification of Tumours 2000, 31-36. IARC Press, Lyon.
4. Massagué J. TGFbeta in cancer. Cell 2008, 134:215-230. 10.1016/j.cell.2008.07.001.
5. Lewis M.P., Lygoe K.A., Nystrom M.L., Anderson W.P., Speight P.M., Marshall J.F., et al. Tumour-derived TGF-β1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br. J. Cancer 2004, 90:822-832. 10.1038/sj.bjc.6601611.
6. Levy L., Hill C.S. Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 2006, 17:41-58. 10.1016/j.cytogfr.2005.09.009.
7. Prime S.S., Davies M., Pring M., Paterson I.C. The Role of TGF-β in epithelial malignancy and its relevance to the pathogenesis of oral cancer (Part II). Crit. Rev. Oral Biol. Med. 2004, 15:337-347. 10.1177/154411130401500603.
8. Bian Y., Hall B., Sun Z.-J., Molinolo A., Chen W., Gutkind J.S., et al. Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene 2012, 31:3322-3332. 10.1038/onc.2011.494.
9. Guasch G., Schober M., Pasolli H.A., Conn E.B., Polak L., Fuchs E. Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell 2007, 12:313-327. 10.1016/j.ccr.2007.08.020.
10. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004, 303:848-851. 10.1126/science.1090922.
11. Cheng N., Bhowmick N.A., Chytil A., Gorksa A.E., Brown K.A., Muraoka R., et al. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 2005, 24:5053-5068. 10.1038/sj.onc.1208685.
12. Andl C.D., McCowan K.M., Allison G.L., Rustgi A.K. Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner. Neoplasia 2010, 12:485-498.
13. Andl C.D., Fargnoli B.B., Okawa T., Bowser M., Takaoka M., Nakagawa H., et al. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo. Cancer Res. 2006, 66:9878-9885. 10.1158/0008-5472.CAN-05-4157.
14. Andl C.D., Mizushima T., Nakagawa H., Oyama K., Harada H., Chruma K., et al. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J. Biol. Chem. 2003, 278:1824-1830. 10.1074/jbc.M209148200.
15. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9:671-675. 10.1038/nmeth.2089.
16. Le Bras G.F., Allison G.L., Richards N.F., Ansari S.S., Washington M.K., Andl C.D. CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion. PloS One 2011, 6:e27063. 10.1371/journal.pone.0027063.
17. Matys V., Kel-Margoulis O.V., Fricke E., Liebich I., Land S., Barre-Dirrie A., et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 2006, 34:D108-D110. 10.1093/nar/gkj143.
18. Portales-Casamar E., Thongjuea S., Kwon A.T., Arenillas D., Zhao X., Valen E., et al. JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res. 2010, 38:D105-D110. 10.1093/nar/gkp950.
19. Zhang B., Kirov S., Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005, 33:W741-W748. 10.1093/nar/gki475.
20. Kadaba R., Birke H., Wang J., Hooper S., Andl C.D., Di Maggio F., et al. Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes. J. Pathol. 2013, 230:107-117. 10.1002/path.4172.
21. Lu X., Wang Q., Hu G., Van Poznak C., Fleisher M., Reiss M., et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009, 23:1882-1894. 10.1101/gad.1824809.
22. Ivaska J., Heino J. Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu. Rev. Cell Dev. Biol. 2011, 27:291-320. 10.1146/annurev-cellbio-092910-154017.
23. Yu X., Miyamoto S., Mekada E. Integrin alpha 2 beta 1-dependent EGF receptor activation at cell-cell contact sites. J. Cell Sci. 2000, 113:2139-2147.
24. Zaman M.H., Trapani L.M., Sieminski A.L., MacKellar D., Gong H., Kamm R.D., et al. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc. Natl. Acad. Sci. 2006, 103:10889-10894. 10.1073/pnas.0604460103.
25. Thomas G.J., Lewis M.P., Hart I.R., Marshall J.F., Speight P.M. αvβ6integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int. J. Cancer. 2001, 92:641-650. 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P.
26. Macias H., Moran A., Samara Y., Moreno M., Compton J.E., Harburg G., et al. SLIT/ROBO1 Signaling suppresses mammary branching morphogenesis by limiting basal cell number. Dev. Cell. 2011, 20:827-840. 10.1016/j.devcel.2011.05.012.
27. Ghosh S., Ghosh A., Maiti G.P., Alam N., Roy A., Roychoudhury S., et al. Alterations of ROBO1/DUTT1 and ROBO2 loci in early dysplastic lesions of head and neck: clinical and prognostic implications. Hum. Genet. 2009, 125:189-198. 10.1007/s00439-008-0610-9.
28. Vanderploeg J., Vazquez Paz L.L., MacMullin A., Jacobs J.R. Integrins are required for cardioblast polarisation in Drosophila, BMC. Dev. Biol. 2012, 12:8. 10.1186/1471-213X-12-8.
29. Stevens A., Jacobs J.R. Integrins regulate responsiveness to slit repellent signals. J. Neurosci. Off. J. Soc. Neurosci. 2002, 22:4448-4455. (doi:20026413).
30. Engle S.J., Ormsby I., Pawlowski S., Boivin G.P., Croft J., Balish E., et al. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res. 2002, 62:6362-6366.
31. Monteleone G., Mann J., Monteleone I., Vavassori P., Bremner R., Fantini M., et al. A failure of transforming growth factor-β1 negative regulation maintains sustained NF-κB activation in gut Inflammation. J. Biol. Chem. 2004, 279:3925-3932. 10.1074/jbc.M303654200.
32. Cohen J., Chen Z., Lu S.-L., Yang X.P., Arun P., Ehsanian R., et al. Attenuated transforming growth factor β signaling promotes nuclear factor-κb activation in head and neck cancer. Cancer Res. 2009, 69:3415-3424. 10.1158/0008-5472.CAN-08-3704.
33. Freudlsperger C., Bian Y., Contag Wise S., Burnett J., Coupar J., Yang X., et al. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene 2013, 32:1549-1559. 10.1038/onc.2012.171.
34. Chen L., Arbieva Z.H., Guo S., Marucha P.T., Mustoe T.A., DiPietro L.A. Positional differences in the wound transcriptome of skin and oral mucosa. BMC Genomics 2010, 11:471. 10.1186/1471-2164-11-471.
35. Knowles L.M., Stabile L.P., Egloff A.M., Rothstein M.E., Thomas S.M., Gubish C.T., et al. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer. Clin. Cancer Res. 2009, 15:3740-3750. 10.1158/1078-0432.CCR-08-3252.
36. Ren Y., Cao B., Law S., Xie Y., Lee P.Y., Cheung L., et al. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin. Cancer Res. 2005, 11:6190-6197. 10.1158/1078-0432.CCR-04-2553.
37. Ji J., Zhao L., Wang X., Zhou C., Ding F., Su L., et al. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 2004, 130:480-486. 10.1007/s00432-004-0555-x.
38. Kaur J., Matta A., Kak I., Srivastava G., Assi J., Leong I., et al. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int. J. Cancer J. Int. Cancer 2014, 134:1379-1388. 10.1002/ijc.28473.
39. Tripathi S.C., Matta A., Kaur J., Grigull J., Chauhan S.S., Thakar A., et al. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One 2010, 5:e11939. 10.1371/journal.pone.0011939.
40. Bitzer M., von Gersdorff G., Liang D., Dominguez-Rosales A., Beg A.A., Rojkind M., et al. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev. 2000, 14:187-197. 10.1101/gad.14.2.187.
41. Yan X., Liu Z., Chen Y. Regulation of TGF-β signaling by Smad7. Acta Biochim. Biophys. Sin. 2009, 41:263-272. 10.1093/abbs/gmp018.
42. Benus G.F.J.D., Wierenga A.T.J., de Gorter D.J.J., Schuringa J.J., van Bennekum A.M., Drenth-Diephuis L., et al. Inhibition of the transforming growth factor β (TGFβ) pathway by interleukin-1β is mediated through TGFβ-activated kinase 1 phosphorylation of SMAD3. Mol. Biol. Cell. 2005, 16:3501-3510. 10.1091/mbc.E04-11-1033.
43. Baugé C., Legendre F., Leclercq S., Elissalde J.M., Pujol J.P., Galéra P., et al. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum. 2007, 56:3020-3032. 10.1002/art.22840.
44. Kiskowski M.A., Jackson R.S., Banerjee J., Li X., Kang M., Iturregui J.M., et al. Role for stromal heterogeneity in prostate tumorigenesis. Cancer Res. 2011, 71:3459-3470. 10.1158/0008-5472.CAN-10-2999.
45. Grugan K.D., Miller C.G., Yao Y., Michaylira C.Z., Ohashi S., Klein-Szanto A.J., et al. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc. Natl. Acad. Sci. USA 2010, 107:11026-11031. 10.1073/pnas.0914295107.
46. Daly A.J., McIlreavey L., Irwin C.R. Regulation of HGF and SDF-1 expression by oral fibroblasts - Implications for invasion of oral cancer. Oral Oncol. 2008, 44:646-651. 10.1016/j.oraloncology.2007.08.012.
47. McKeown S.T.W., Hyland P.L., Locke M., Mackenzie I.C., Irwin C.R. Keratinocyte growth factor and scatter factor expression by regionally defined oral fibroblasts. Eur. J. Oral Sci. 2003, 111:42-50.
48. Kim B.-G., Li C., Qiao W., Mamura M., Kasprzak B., Kasperczak B., et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 2006, 441:1015-1019. 10.1038/nature04846.
49. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906. 10.1016/j.cell.2009.10.027.
50. Provenzano P.P., Inman D.R., Eliceiri K.W., Knittel J.G., Yan L., Rueden C.T., et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008, 6:11. 10.1186/1741-7015-6-11.
51. Pickup M.W., Laklai H., Acerbi I., Owens P., Gorska A.E., Chytil A., et al. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas. Cancer Res. 2013, 73:5336-5346. 10.1158/0008-5472.CAN-13-0012.
52. Calvo F., Ege N., Grande-Garcia A., Hooper S., Jenkins R.P., Chaudhry S.I., et al. Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts. Nat. Cell Biol. 2013, 15. 10.1038/ncb2756.
53. Ehrbar M., Sala A., Lienemann P., Ranga A., Mosiewicz K., Bittermann A., et al. Elucidating the role of matrix stiffness in 3D cell migration and remodeling. Biophys. J. 2011, 100:284-293. 10.1016/j.bpj.2010.11.082.
54. Krstic J., Santibanez J.F. Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. Sci. World J. 2014, 2014. 10.1155/2014/521754.
55. Kurahara S., Shinohara M., Ikebe T., Nakamura S., Beppu M., Hiraki A., et al. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999, 21:627-638.
56. Patel B.P., Shah P.M., Rawal U.M., Desai A.A., Shah S.V., Rawal R.M., et al. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J. Surg. Oncol. 2005, 90:81-88. 10.1002/jso.20240.
57. Rosenthal E.L., Matrisian L.M. Matrix metalloproteases in head and neck cancer. Head Neck 2006, 28:639-648. 10.1002/hed.20365.
58. Smith J., Rattay T., McConkey C., Helliwell T., Mehanna H. Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol. 2009, 45:647-653. 10.1016/j.oraloncology.2009.02.006.
59. Sabeh F., Shimizu-Hirota R., Weiss S.J. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol. 2009, 185:11-19. 10.1083/jcb.200807195.
60. de Arao Tan I., Ricciardelli C., Russell D.L. The metalloproteinase ADAMTS1: A comprehensive review of its role in tumorigenic and metastatic pathways. Int. J. Cancer. 2013, 133:2263-2276. 10.1002/ijc.28127.
61. Lind T., Birch M.A., McKie N. Purification of an insect derived recombinant human ADAMTS-1 reveals novel gelatin (type I collagen) degrading activities. Mol. Cell. Biochem. 2006, 281:95-102. 10.1007/s11010-006-0637-y.
62. Ng Y.H., Zhu H., Pallen C.J., Leung P.C.K., MacCalman C.D. Differential effects of interleukin-1beta and transforming growth factor-beta1 on the expression of the inflammation-associated protein, ADAMTS-1, in human decidual stromal cells in vitro. Hum. Reprod. Oxf. Engl. 2006, 21:1990-1999. 10.1093/humrep/del108.
63. Rocks N., Paulissen G., Quesada-Calvo F., Munaut C., Gonzalez M.-L.A., Gueders M., et al. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Res. 2008, 68:9541-9550. 10.1158/0008-5472.CAN-08-0548.
64. Turksen K., Choi Y., Fuchs E. Transforming growth factor alpha induces collagen degradation and cell migration in differentiating human epidermal raft cultures. Cell Regul. 1991, 2:613-625.
65. Shiozaki H., Kadowaki T., Doki Y., Inoue M., Tamura S., Oka H., et al. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line. Br. J. Cancer. 1995, 71:250-258.
66. Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J.F., Harrington K., et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 2007, 9:1392-1400. 10.1038/ncb1658.
67. Margadant C., Sonnenberg A. Integrin-TGF-? crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 2010, 11:97-105. 10.1038/embor.2009.276.
68. Mierke C.T. The integrin alphav beta3 increases cellular stiffness and cytoskeletal remodeling dynamics to facilitate cancer cell invasion. New J. Phys. 2013, 15:015003. 10.1088/1367-2630/15/1/015003.
69. Kaur P., Carter W.G. Integrin expression and differentiation in transformed human epidermal cells is regulated by fibroblasts. J. Cell Sci. 1992, 103:755-763.
70. Jacquemet G., Green D.M., Bridgewater R.E., von Kriegsheim A., Humphries M.J., Norman J.C., et al. RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1-IQGAP1 complex. J. Cell Biol. 2013, 202:917-935. 10.1083/jcb.201302041.
71. Kim J.P., Zhang K., Kramer R.H., Schall T.J., Woodley D.T. Integrin receptors and RGD sequences in human keratinocyte migration: unique anti-migratory function of alpha 3 beta 1 epiligrin receptor. J. Invest. Dermatol. 1992, 98:764-770.
72. Chang P.-H., Hwang-Verslues W.W., Chang Y.-C., Chen C.-C., Hsiao M., Jeng Y.-M., et al. Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/?-catenin pathway. Cancer Res. 2012, 72:4652-4661. 10.1158/0008-5472.CAN-12-0877.
73. Labbé E., Lock L., Letamendia A., Gorska A.E., Gryfe R., Gallinger S., et al. Transcriptional cooperation between the transforming growth factor-β and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res. 2007, 67:75-84. 10.1158/0008-5472.CAN-06-2559.
74. Marlow R., Strickland P., Lee J.S., Wu X., PeBenito M., Binnewies M., et al. SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res. 2008, 68:7819-7827. 10.1158/0008-5472.CAN-08-1357.
75. Stella M.C., Trusolino L., Comoglio P.M. The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis. Mol. Biol. Cell. 2009, 20:642-657. 10.1091/mbc.E08-03-0321.